Hyperammonemia Global Clinical Trials Review, H1, 2014

GlobalData
April 30, 2014
78 Pages - GLDATA18038
$2,500.00

Summary

GlobalData's clinical trial report, “Hyperammonemia Global Clinical Trials Review, H1, 2014" provides data on the Hyperammonemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperammonemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperammonemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyperammonemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Hyperammonemia 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hyperammonemia Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Hyperammonemia 30
Mar 10, 2014: Mecasermin treatment for Rett Syndrome is safe and well-tolerated 30
Nov 22, 2012: Neuren Completes NNZ-2566 Oral Phase I Safety Study And Files IND With FDA For Rett Syndrome 30
Nov 02, 2009: UCL (University College London) Liver Failure Group Present Two Studies On A Novel Treatment Option (OCR-002) For Complications Of Hyperammonemia In Liver Failure At The 60th Annual AASLD Meeting 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Ocera Therapeutics, Inc. 32
Clinical Trial Overview of Ocera Therapeutics, Inc. 32
Neurolixis Inc. 33
Clinical Trial Overview of Neurolixis Inc. 33
Neuren Pharmaceuticals Limited 34
Clinical Trial Overview of Neuren Pharmaceuticals Limited 34
Hyperion Therapeutics, Inc. 35
Clinical Trial Overview of Hyperion Therapeutics, Inc. 35
Edison Pharmaceuticals, Inc. 36
Clinical Trial Overview of Edison Pharmaceuticals, Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
Children's Research Institute 37
Clinical Trial Overview of Children's Research Institute 37
Boston Children's Hospital 38
Clinical Trial Overview of Boston Children's Hospital 38
Faculdades Metropolitanas Unidas 39
Clinical Trial Overview of Faculdades Metropolitanas Unidas 39
University of Utah Health Care 40
Clinical Trial Overview of University of Utah Health Care 40
The Children's Mercy Hospital 41
Clinical Trial Overview of The Children's Mercy Hospital 41
The Children's Hospital of Philadelphia 42
Clinical Trial Overview of The Children's Hospital of Philadelphia 42
Assistance Publique Hopitaux De Marseille 43
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 43
The Sheba Medical Center 44
Clinical Trial Overview of The Sheba Medical Center 44
University Hospital Basel 45
Clinical Trial Overview of University Hospital Basel 45
Five Key Clinical Profiles 46
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 78

List of Tables
Hyperammonemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hyperammonemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hyperammonemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hyperammonemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Hyperammonemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hyperammonemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hyperammonemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Hyperammonemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hyperammonemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hyperammonemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hyperammonemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hyperammonemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hyperammonemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hyperammonemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hyperammonemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hyperammonemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Hyperammonemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hyperammonemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Hyperammonemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hyperammonemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hyperammonemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2014* 32
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurolixis Inc., 2014* 33
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuren Pharmaceuticals Limited, 2014* 34
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyperion Therapeutics, Inc., 2014* 35
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Edison Pharmaceuticals, Inc., 2014* 36
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Research Institute, 2014* 37
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 38
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculdades Metropolitanas Unidas, 2014* 39
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Utah Health Care, 2014* 40
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Mercy Hospital, 2014* 41
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2014* 42
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2014* 43
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 44
Hyperammonemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 45

List of Figures
Hyperammonemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hyperammonemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hyperammonemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hyperammonemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Hyperammonemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hyperammonemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hyperammonemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hyperammonemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hyperammonemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hyperammonemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Hyperammonemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hyperammonemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hyperammonemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hyperammonemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Hyperammonemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hyperammonemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hyperammonemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 77

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax